Department of Clinical Sciences, Lund University, Malmö, Sweden.
Clinical Infection Medicine, Department of Translational Medicine, Lund University, Malmö, Sweden.
HLA. 2020 Dec;96(6):681-687. doi: 10.1111/tan.14119. Epub 2020 Oct 30.
Most patients with celiac disease are positive for either HLA-DQA105:01-DQB102 (DQ2.5) or DQA103:01-DQB103:02 (DQ8). Remaining few patients are usually DQA102:01-DQB102 (DQ2.2) carriers. Screenings of populations with high frequencies of these HLA-DQA1-DQB1 haplotypes report a 1% to 3% celiac disease prevalence. The aim was to determine the prevalence of HLA-DQ risk haplotypes for celiac disease in Ethiopian children. Dried blood spots collected from 1193 children from the Oromia regional state of Ethiopia were genotyped for HLA-DQA1 and DQB1 genotyping using an asymmetric polymerase chain reaction (PCR) and a subsequent hybridization of allele-specific probes. As references, 2000 previously HLA-genotyped children randomly selected from the general population in Sweden were included. DQ2.2 was the most common haplotype and found in 15.3% of Ethiopian children, which was higher compared with 6.7% of Swedish references (P < .0001). Opposed to this finding, DQ2.5 and DQ8 occurred in 9.7% and 6.8% of Ethiopian children, which were less frequent compared with 12.8% and 13.1% of Swedish references, respectively (P < .0001). The DQ2.5-trans genotype encoded by DQA105-DQB103:01 in combination with DQ2.2 occurred in 3.6% of Ethiopian children, which was higher compared with 1.3% of Swedish references (P < .0001). However, when children with moderate high to very high-risk HLA genotypes were grouped together, there was no difference between Ethiopian children and Swedish references (27.4% vs 29.0%) (P = .3504). The frequency of HLA risk haplotypes for celiac disease is very similar in Ethiopian and Swedish children. This finding of importance will be useful in future screening of children for celiac disease in Ethiopia.
大多数乳糜泻患者的 HLA-DQA105:01-DQB102(DQ2.5)或 DQA103:01-DQB103:02(DQ8)呈阳性。其余少数患者通常为 DQA102:01-DQB102(DQ2.2)携带者。对这些 HLA-DQA1-DQB1 单倍型频率较高的人群进行筛查,报告的乳糜泻患病率为 1%至 3%。目的是确定埃塞俄比亚儿童乳糜泻的 HLA-DQ 风险单倍型的流行率。从埃塞俄比亚奥罗米亚地区的 1193 名儿童中采集干血斑,使用不对称聚合酶链反应(PCR)对 HLA-DQA1 和 DQB1 进行基因分型,然后杂交等位基因特异性探针。作为参考,纳入了 2000 名从瑞典普通人群中随机选择的 HLA 基因分型的儿童。DQ2.2 是最常见的单倍型,在 15.3%的埃塞俄比亚儿童中发现,高于瑞典参考人群的 6.7%(P <.0001)。与这一发现相反,DQ2.5 和 DQ8 在 9.7%和 6.8%的埃塞俄比亚儿童中发现,低于瑞典参考人群的 12.8%和 13.1%(P <.0001)。由 DQA105-DQB103:01 编码的 DQ2.5 转移基因型与 DQ2.2 结合在 3.6%的埃塞俄比亚儿童中发现,高于瑞典参考人群的 1.3%(P <.0001)。然而,当将具有中高至高风险 HLA 基因型的儿童归为一组时,埃塞俄比亚儿童和瑞典参考人群之间没有差异(27.4%对 29.0%)(P =.3504)。乳糜泻的 HLA 风险单倍型在埃塞俄比亚和瑞典儿童中非常相似。这一发现具有重要意义,将有助于未来在埃塞俄比亚对儿童进行乳糜泻筛查。